Ablation of CHOP, selective activation of ATF6 or PERK, disruption of CDK5 and MEKK1 pathway, or the stimulation of ERAD may serve as a powerful therapeutic strategy against rhodopsin mutants induced RP and reverse severe retinal degeneration [29–32]. This evidence concerns the gene MAP3K1 and retinal degeneration.